← Leaderboards
Janice J Endsley
University Of Texas Med Br Galveston
$8,720,531
Attributed
$18,897,890
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,897,890 · 11
By mechanism
R01$13,231,092 · 5
R33$2,327,004 · 1
R61$1,498,529 · 1
R21$834,805 · 2
R56$637,562 · 1
T32$368,898 · 1
Top collaborators
- Benjamin B. Gelman9 shared
- Chinnaswamy Jagannath7 shared
- Evans I Amukoye5 shared
- Ashok K Chopra2 shared
- Arshad Khan2 shared
- Jai Rudra2 shared
- Scott C Weaver2 shared
- Guohua Yi2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Evans I Amukoye$1,488,702
- Mark Endsley$262,826
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisImmuneT-LymphocyteLungCellsCytokineImmune ResponseMediatingIn VivoResponseIn VitroMacrophageMolecularPathologyDefectCo-InfectionInflammatoryImmune FunctionHumanized MouseMouse ModelPublic HealthAnimal ModelInfection
Grant awards (28)
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages$1,236,573
R01 · FY2025 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$948,345
R01 · FY2025 · AI
C type Lectin Pathway Regulates Macrophage Immune Metabolism in Mtb-Infected Lung$788,478
R01 · FY2025 · HL · contact PI
Biodefense Training Program$193,604
T32 · FY2025 · AI
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages$1,297,775
R01 · FY2024 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$958,345
R01 · FY2024 · AI
Biodefense Training Program$175,294
T32 · FY2024 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$959,375
R01 · FY2023 · AI
Role of IL-17 Cytokine Networks in TB Relapse Due to HIV$601,802
R01 · FY2023 · AI · contact PI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$959,375
R01 · FY2022 · AI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection$775,668
R33 · FY2022 · AI · contact PI
Role of IL-17 Cytokine Networks in TB Relapse Due to HIV$589,202
R01 · FY2022 · AI · contact PI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$974,750
R01 · FY2021 · AI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection$775,668
R33 · FY2021 · AI · contact PI
Role of IL-17 Cytokine Networks in TB Relapse Due to HIV$574,424
R01 · FY2021 · AI · contact PI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection$775,668
R33 · FY2020 · AI · contact PI
Role of IL-17 Cytokine Networks in TB Relapse Due to HIV$657,714
R01 · FY2020 · AI · contact PI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection$750,254
R61 · FY2019 · AI · contact PI
Role of IL-17 Cytokine Networks in TB Relapse Due to HIV$554,261
R01 · FY2019 · AI · contact PI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection$748,275
R61 · FY2018 · AI · contact PI
HIV-induced Defects in Pulmonary Macrophages Exacerbate Mycobacterium Tuberculosis Co-infection$705,641
R01 · FY2018 · HL · contact PI
HIV-induced Defects in Pulmonary Macrophages Exacerbate Mycobacterium Tuberculosis Co-infection$705,641
R01 · FY2017 · HL · contact PI
Self-assembling Peptide Nanomaterials for Eliciting Mucosal CD8+ T cell Immunity$188,800
R21 · FY2017 · AI
HIV-induced Defects in Pulmonary Macrophages Exacerbate Mycobacterium Tuberculosis Co-infection$719,391
R01 · FY2016 · HL · contact PI
Self-assembling Peptide Nanomaterials for Eliciting Mucosal CD8+ T cell Immunity$227,550
R21 · FY2016 · AI
HIV-induced Defects in Pulmonary Macrophages Exacerbate Mycobacterium Tuberculosis Co-infection$637,562
R56 · FY2015 · HL · contact PI
A Humanized Mouse Model to Study HIV/Mtb Co-infection$227,205
R21 · FY2011 · AI · contact PI
A Humanized Mouse Model to Study HIV/Mtb Co-infection$191,250
R21 · FY2010 · AI · contact PI